Case Report: Reopening the anabolic window — romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients

• by Simona Barbuto, Paolo Mastromauro, Guido Zavatta, Daniele Vetrano, Anna Mistretta, Nicolò Bisceglia, Giorgia Comai, Uberto Pagotto, Gaetano La Manna, Giuseppe Cianciolo

• September 4, 2026

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

• by Andrea Surnit

• June 30, 2026

• 3 min

Screening and validation of ZFYVE27 as a potential diagnostic biomarker for osteoporosis via integrative bioinformatics and machine learning approaches

• by Libo Zhou, Zirui Liu, Zhongcheng Liu, Lei Wen, Maoqiang Lin, Bin Geng, Yayi Xia

• June 24, 2026

Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management

As osteoporosis treatment continues to evolve, clinicians are moving beyond bone mineral density scores alone and placing greater emphasis on fracture risk when making therapeutic decisions

• by

• July 8, 2026

• 7 min